Partners in crime: beta-cells and autoimmune responses complicit in type 1 diabetes pathogenesis

E Toren, KLS Burnette, RR Banerjee… - Frontiers in …, 2021 - frontiersin.org
Type 1 diabetes (T1D) is an autoimmune disease characterized by autoreactive T cell-
mediated destruction of insulin-producing pancreatic beta-cells. Loss of beta-cells leads to …

The murine autoimmune diabetes model: NOD and related strains

H Kikutani, S Makino - Advances in immunology, 1992 - Elsevier
Publisher Summary This chapter summarizes the experimental findings and observations
based on the nonobese diabetic (NOD) mouse model and discusses the pathogenesis and …

The first external domain of the nonobese diabetic mouse class II IA beta chain is unique.

H Acha-Orbea, HO McDevitt - Proceedings of the National …, 1987 - National Acad Sciences
The nonobese diabetic mouse is recognized as an important animal model for human
insulin-dependent diabetes mellitus. One of the components of susceptibility to this disease …

B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice

H Noorchashm, N Noorchashm, J Kern, SY Rostami… - Diabetes, 1997 - Am Diabetes Assoc
Nonobese diabetic (NOD) mice spontaneously develop an acute onset of hyperglycemia
reminiscent of human type I diabetes. The disease is the end result of a mononuclear cell …

Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice

LS Wicker, BJ Miller, Y Mullen - Diabetes, 1986 - Am Diabetes Assoc
The nonobese diabetic (NOD) mouse, a model of human type I diabetes, develops insulitis
beginning at 4–6 wk of age. By 30 wk of age, 72% of females and 39% of males develop …

Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1.

CO Jacob, S Aiso, SA Michie… - Proceedings of the …, 1990 - National Acad Sciences
The role of tumor necrosis factor alpha (TNF-alpha) in the pathogenesis of autoimmune
diabetes mellitus was tested in the nonobese mouse (NOD) model system. The effects of …

Prevention of type I diabetes in NOD mice by adjuvant immunotherapy

MWJ Sadelain, HY Qin, J Lauzon, B Singh - Diabetes, 1990 - Am Diabetes Assoc
The nonobese diabetic (NOD) mouse is an excellent model of insulin-dependent (type I)
human diabetes mellitus. We report that a single injection of complete Freund's adjuvant …

Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes

JA Shizuru, C Taylor-Edwards, BA Banks, AK Gregory… - Science, 1988 - science.org
Spontaneous diabetes mellitus was blocked in nonobese diabetic mice by treatment with a
monoclonal antibody against the L3T4 determinant present on the surface of T-helper …

Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages

P Hutchings, H Rosen, L O'Reilly, E Simpson… - Nature, 1990 - nature.com
INSULIN-dependent diabetes mellitus (IDDM) is a disease with an autoimmune aetiology.
The non-obese diabetic mouse is a good spontaneous animal model of the human disease …

Prevention of onset in an insulin‐dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei

T Matsuzaki, Y NAGATA, S KADO, K UCHIDA, I KATO… - Apmis, 1997 - Wiley Online Library
The effects of Lactobacillus casei (LC) on the onset of diabetes in an insulin‐dependent
diabetes mellitus model, nonobese diabetic (NOD) mice, were examined. From the age of 4 …